Pacific Biosciences of California, Inc.
PACB
$1.33
$0.064.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.37M | -38.00M | -41.93M | -426.08M | 2.37M |
| Total Depreciation and Amortization | 4.65M | 4.40M | 4.58M | 372.78M | 10.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.16M | 11.68M | 11.84M | 11.63M | -52.34M |
| Change in Net Operating Assets | 7.49M | 3.21M | -3.87M | -2.39M | 8.37M |
| Cash from Operations | -19.07M | -18.71M | -29.38M | -44.06M | -30.65M |
| Capital Expenditure | -861.00K | 86.00K | -550.00K | -1.39M | -1.62M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.89M | 18.82M | 25.83M | 46.62M | 59.86M |
| Cash from Investing | 26.03M | 18.90M | 25.28M | 45.23M | 58.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -50.20M |
| Issuance of Common Stock | 0.00 | 1.47M | 0.00 | 1.96M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 1.47M | 0.00 | 1.96M | -50.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.96M | 1.66M | -4.09M | 3.14M | -22.61M |